Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Brock

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
Genetic Epidemiology|May 18, 2007
A hierarchical model for estimating significance levels of non-parametric linkage statistics for large pedigreesGuy N Brock, Daniel E Weeks, Eric Sobel, et al.
Chest|January 1, 1991
Pulmonary complications of combination therapy with cyclophosphamide and prednisoneR P Sen, T E Walsh, W Fisher, et al.
Cancer Investigation|January 1, 1988
Basis and new developments in the field of oxazaphosphorinesN Brock, P Hilgard, M Peukert, et al.
Arzneimittel-Forschung|November 1, 1974
[The toxicology of the combination drug dilazep/beta-acetyldigoxin]V H Abel, N Brock, J Pohl, et al.
BMC Medical Research Methodology|October 28, 2011
How to handle mortality when investigating length of hospital stay and time to clinical stabilityGuy N Brock, Christopher Barnes, Julio A Ramirez, et al.
Arzneimittel-Forschung|January 1, 1983
[Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)]E Kunze, B Köhnecke, W Engelhardt, et al.
Arzneimittel-Forschung|January 1, 1979
Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamideN Brock, J Stekar, J Pohl, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiolsN Brock, P Hilgard, J Pohl, et al.
Arzneimittel-Forschung|January 1, 1981
Pharmacological and toxicological properties of azelastine, a novel antiallergic agentH J Zechel, N Brock, D Lenke, et al.
Genomics Data|October 21, 2015
Use of multiple time points to model parotid differentiationMelissa A Metzler, Savitri Appana, Guy N Brock, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Genetic Epidemiology|May 18, 2007
A hierarchical model for estimating significance levels of non-parametric linkage statistics for large pedigreesGuy N Brock, Daniel E Weeks, Eric Sobel, et al.
Chest|January 1, 1991
Pulmonary complications of combination therapy with cyclophosphamide and prednisoneR P Sen, T E Walsh, W Fisher, et al.
Cancer Investigation|January 1, 1988
Basis and new developments in the field of oxazaphosphorinesN Brock, P Hilgard, M Peukert, et al.
Arzneimittel-Forschung|November 1, 1974
[The toxicology of the combination drug dilazep/beta-acetyldigoxin]V H Abel, N Brock, J Pohl, et al.
BMC Medical Research Methodology|October 28, 2011
How to handle mortality when investigating length of hospital stay and time to clinical stabilityGuy N Brock, Christopher Barnes, Julio A Ramirez, et al.
Arzneimittel-Forschung|January 1, 1983
[Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)]E Kunze, B Köhnecke, W Engelhardt, et al.
Arzneimittel-Forschung|January 1, 1979
Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamideN Brock, J Stekar, J Pohl, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiolsN Brock, P Hilgard, J Pohl, et al.
Arzneimittel-Forschung|January 1, 1981
Pharmacological and toxicological properties of azelastine, a novel antiallergic agentH J Zechel, N Brock, D Lenke, et al.
Genomics Data|October 21, 2015
Use of multiple time points to model parotid differentiationMelissa A Metzler, Savitri Appana, Guy N Brock, et al.
Pageof 20